Close menu




Investments

Photo credits: pixabay.com

Commented by Stefan Feulner on October 10th, 2022 | 10:43 CEST

BioNTech, Fonterelli GmbH & Co KGaA, Fonterelli SPAC 2 AG, MorphoSys - Bullish forecasts

  • Investments
  • Biotechnology
  • Covid19

The capital-intensive biotech and pharma sector has been stuck in a correction since the central banks changed their strategy at the beginning of the stock market year. In particular, vaccine manufacturers, which have exploded since the outbreak of COVID-19, have lost disproportionately in value since their highs in August of last year. However, the pandemic is likely to be with us for the next few years, albeit in a weakened form. The development of new drugs benefits companies that could now face a similar path as the vaccine producers.

Read

Commented by Armin Schulz on October 6th, 2022 | 10:42 CEST

ProSiebenSat.1 Media, Aspermont, Alibaba - Growth stocks with significant rebound potential

  • Investments
  • Digitization
  • Technology

On Friday, September 30, a key support level in the S&P 500 seemed to have fallen, but it was a false breakout, as could be seen the following Monday. A popular move by big players in the market who want to fish stops and then buy in cheaply. After the panic, the FOMO (fear-of-missing-out) phenomenon occurs. Investors who are stopped out realize their mistake and try to get back into the market as quickly as possible so as not to miss the rise. To do this, investors who have shorted the market close their positions, providing additional upside. Now it is a matter of finding the stocks that have been punished too much. We take a look at three growth stocks today.

Read

Commented by Stefan Feulner on October 4th, 2022 | 11:59 CEST

RWE, Pathfinder Ventures, United Internet - Panic as an opportunity

  • Camping
  • Investments

Last week, the crash prophets crawled out of their caves and outdid themselves with forecasts reaching the Corona lows at around 8,000 points in the leading German DAX index. Without a doubt, the general conditions for a sustained stock rally are moderate with the escalation of the Ukraine situation and concerns about further interest rate hikes. Nevertheless, there are attractive entry opportunities at the current level, which could pay off in cash in the long term.

Read

Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

  • Biotechnology
  • Pharma
  • Investments
  • Technology

About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

Read

Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

  • Technology
  • Biotechnology
  • Investments

The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

Read

Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

Verbio, Kleos Space, KWS Saat - This news is moving share prices!

  • Space
  • Technology
  • Investments

Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

Read

Commented by Fabian Lorenz on September 28th, 2022 | 11:22 CEST

Time for bargain hunters? Plug Power, Varta and Pathfinder Ventures

  • Investments
  • Camping
  • RV
  • Electromobility

Growth stocks are currently under particular pressure. But this can also create opportunities for bargain hunters. Perhaps in the case of Varta? The share has crashed sharply after a profit warning. Now, the first analyst has upgraded the share from "sell" to "buy". But even his reasoning does not sound like a new growth story. Plug Power also tends to live on the hope of growth. While the new production facility is technically a milestone, it needs more. In contrast, things are going well at Pathfinder Ventures. The still unknown tourism company is profiting from the camping boom in North America, and its valuation is anything but expensive.

Read

Commented by Stefan Feulner on September 27th, 2022 | 13:47 CEST

Barrick Gold, Tocvan Ventures, Newmont, Glencore - Long-term positioning in gold makes sense

  • Mining
  • Gold
  • Commodities
  • Investments

The FED's recent interest rate hikes and Chairman Jerome Powell's statement sent both equity and precious metals markets into the valley of tears. By all means, the monetary guardians want to curb rampant inflation. Whether this will succeed seems at least questionable. After all, it should not be forgotten that this would put an end to the already sputtering engine of the global economy. In addition, many already highly indebted countries are falling into ever greater problems due to higher interest payments. Thus, it is time to take a long-term, anticyclical position in the precious metals sector.

Read

Commented by Nico Popp on September 27th, 2022 | 12:46 CEST

Deutsche Bank, Desert Gold, Uniper: Watch out for the financial crisis!

  • Mining
  • Gold
  • Investments
  • crisis

The energy crisis is pushing utilities to the brink, the election victory of the radical right-wing party Fratelli d'Italia is putting a strain on the EU - and what are banks doing in this context? Weeks ago, Germany's top banking supervisor Raimund Rösler warned that the rapid turnaround in interest rates could also overburden some institutions. We look at banks, gas traders and a possible laughing third party.

Read

Commented by Stefan Feulner on September 26th, 2022 | 12:57 CEST

Hypoport, Saturn Oil + Gas, Deutsche Bank - Hard-hitting announcements from analysts

  • Mining
  • Oil
  • Investments
  • Inflation

Due to uncertainties in the global economy with fears of recession, blown supply chains coupled with rampant inflation, it is becoming increasingly difficult for companies to maintain their forecasts. The latest example is battery maker Varta, which withdrew its full-year estimates altogether due to increased production costs. Analysts reacted with downgrades. In contrast, despite recent corrections, most financial experts are optimistic for the long term, especially for the commodities sector.

Read